91 related articles for article (PubMed ID: 2716434)
21. Minocycline-induced hyperpigmentation.
Hung PH; Caldwell JB; James WD
J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
[TBL] [Abstract][Full Text] [Related]
22. Hyperpigmentation with daunorubicin therapy.
Kelly TM; Fishman LM; Lessner HE
Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
[No Abstract] [Full Text] [Related]
23. Disorders of the nails and hair associated with human immunodeficiency virus infection.
Prose NS; Abson KG; Scher RK
Int J Dermatol; 1992 Jul; 31(7):453-7. PubMed ID: 1500232
[No Abstract] [Full Text] [Related]
24. Doxorubicin induced hyperpigmentation.
Kumar L; Kochupillai V
N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342686
[No Abstract] [Full Text] [Related]
25. Acanthosis nigricans-like hyperpigmentation secondary to triazinate therapy.
Greenspan AH; Shupack JL; Foo SH; Wise AC
Arch Dermatol; 1985 Feb; 121(2):232-5. PubMed ID: 3977338
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous hyperpigmentation and vidarabine].
Cirera L; Palou J; Estapé J
Med Clin (Barc); 1983 Nov; 81(15):693. PubMed ID: 6656419
[No Abstract] [Full Text] [Related]
27. [Nail hyperpigmentation as a secondary effect of doxorubicin].
Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C
Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110
[No Abstract] [Full Text] [Related]
28. Minocycline-related hyperpigmentation.
Basler RS
Arch Dermatol; 1985 May; 121(5):606-8. PubMed ID: 3158284
[No Abstract] [Full Text] [Related]
29. Photo quiz. Blue-gray centrofacial hyperpigmentation.
Rubegni P; de Aloe G; Maritati E; Mondillo S
Am Fam Physician; 2001 Apr; 63(7):1409-10. PubMed ID: 11310653
[No Abstract] [Full Text] [Related]
30. Doxorubicin-associated hyperpigmentation.
Curran CF
N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
[No Abstract] [Full Text] [Related]
31. [Hyperpigmentation caused by amiodaron].
Lakatos A; Török L; Szücs M; Oze B
Orv Hetil; 1985 Jun; 126(22):1343-5. PubMed ID: 3159995
[No Abstract] [Full Text] [Related]
32. [Hyperpigmentation due to ovulation inhibitors].
Braun-Falco EO
Dtsch Med Wochenschr; 1972 Jan; 97(2):57-8. PubMed ID: 5008206
[No Abstract] [Full Text] [Related]
33. Methacycline hyperpigmentation: a five-year follow-up.
Möller H; Rausing A
Acta Derm Venereol; 1980; 60(6):495-501. PubMed ID: 6162334
[TBL] [Abstract][Full Text] [Related]
34. [Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine].
Zannou DM; Azon-Kouanou A; Bashi BJ; Gougounon A; Zinsou R; Adé G; Houngbè F
Bull Soc Pathol Exot; 2009 May; 102(2):97-8. PubMed ID: 19583030
[TBL] [Abstract][Full Text] [Related]
35. Increasing our understanding of pigmentary disorders.
Grimes P; Nordlund JJ; Pandya AG; Taylor S; Rendon M; Ortonne JP
J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S255-61. PubMed ID: 16631966
[TBL] [Abstract][Full Text] [Related]
36. An animal model for chlorpromazine-induced hyperpigmentation of the skin.
Forrest IS; Aber RC; Kosek JC; Serra MT
Proc West Pharmacol Soc; 1969; 12():36-40. PubMed ID: 5812296
[No Abstract] [Full Text] [Related]
37. [Outbreak of macular hyperpigmentation caused by photosensitivity].
Zorrilla E; Carboney A; Olvera JS; Gutiérrez J; Corona A
Salud Publica Mex; 1982; 24(1):33-8. PubMed ID: 7089700
[No Abstract] [Full Text] [Related]
38. [Amiodarone-induced hyperpigmentation].
Török L; Szekeres L; Lakatos A; Szücs M
Hautarzt; 1986 Sep; 37(9):507-10. PubMed ID: 3771217
[TBL] [Abstract][Full Text] [Related]
39. Hyperpigmentation and atrophy.
Kostas T; Carty MJ; Lin JY; Granter SR; Osman N
J Fam Pract; 2012 Oct; 61(10):617-9. PubMed ID: 23106064
[TBL] [Abstract][Full Text] [Related]
40. The histopathology of subcutaneous minocycline pigmentation.
Bowen AR; McCalmont TH
J Am Acad Dermatol; 2007 Nov; 57(5):836-9. PubMed ID: 17939935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
